Shuttle Pharma Meets Nasdaq Compliance for Stock Listing
![Shuttle Pharma Meets Nasdaq Compliance for Stock Listing](https://investorshangout.com/images/blog/ihnews-Shuttle%20Pharma%20Meets%20Nasdaq%20Compliance%20for%20Stock%20Listing.jpg)
Shuttle Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) is a discovery and development stage specialty pharmaceutical company dedicated to improving the outcomes for cancer patients undergoing radiation therapy. Recently, Shuttle Pharma confirmed that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), also known as the Minimum Bid Price Rule. The notice received from Nasdaq indicated that the company exceeded the $1.00 share price for ten consecutive trading days, which meets the listing requirement.
Overview of Shuttle Pharmaceuticals
Founded in 2012 by members of the Georgetown University Medical Center faculty, Shuttle Pharma focuses on developing therapies aimed at enhancing the effectiveness of radiation therapy (RT). The company’s mission revolves around improving the lives of cancer patients by creating treatments designed to maximize RT's efficacy while minimizing its adverse effects. Radiotherapy is recognized as a foundational method in cancer treatment, and Shuttle Pharma’s research in radiation sensitizers aims to augment cancer cure rates, boost patient survival times, and enhance quality of life for individuals receiving primary treatment or in conjunction with other therapies such as chemotherapy and immunotherapy.
Company’s Commitment to Cancer Care
The commitment of Shuttle Pharma transcends just compliance; it is about advancing scientific understanding and improving clinical outcomes. The company actively works on innovative treatments to support cancer patients, ensuring that their needs are at the forefront of pharmaceutical development. Through its strategic research initiatives, Shuttle Pharma seeks to address critical gaps in current cancer therapies.
Future Prospects and Strategic Direction
As Shuttle Pharma continues to grow, maintaining compliance with stock exchange regulations is crucial for ensuring investor confidence and facilitating future fundraising efforts. By meeting and exceeding the Minimum Bid Price Rule, the company demonstrates stability and a positive trajectory, which can greatly benefit its shareholders. The company is poised to leverage its advancements in research and development to attract new investors and collaborations within the healthcare sector.
Contact Information
For further inquiries, Shuttle Pharmaceuticals can be contacted directly:
Shuttle Pharmaceuticals
Anatoly Dritschilo, M.D., CEO
240-403-4212
Email: info@shuttlepharma.com
Investor Relations
Investor relations are facilitated by Lytham Partners, LLC. For any investment-related questions, reach out to Robert Blum at:
Lytham Partners, LLC
Phone: 602-889-9700
Email: shph@lythampartners.com
Frequently Asked Questions
What is the recent achievement of Shuttle Pharma?
Shuttle Pharma has regained compliance with Nasdaq's Minimum Bid Price Rule, allowing it to maintain its stock listing.
When did Shuttle Pharma regain compliance?
The company received confirmation of its compliance from Nasdaq after trading above the $1.00 limit for ten consecutive days.
What is the main goal of Shuttle Pharmaceuticals?
Shuttle Pharma aims to improve outcomes for cancer patients by developing therapies that enhance radiation therapy effectiveness while reducing side effects.
Where can I find more information about Shuttle Pharma?
More information can be found on the company's official website.
Who should I contact for investor-related inquiries?
For investor inquiries, you can contact Robert Blum at Lytham Partners, LLC.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Growth Forecast for Cosmetic Packaging Machinery Market
- Battery Market Forecast to Reach USD 680.85 Billion
- Recent Net Asset Value Announcement for Hargreave Hale AIM VCT
- Pixalate Reveals Top Grossing CTV Apps for 2024
- Super Micro Computer Faces Challenges Amid Stock Plunge
- Comun Expands Services with New Funding for Immigrant Support
- Loupe Offers Exciting Rewards for Topps Chrome Basketball
- Pinpoint Digital, LLC Transforms Online Presence with New Website
- Security Robots Market Set for Growth to USD 29.65 Billion
- AGAPE ATP Corporation Announces Reverse Stock Split